Skip to main content
. Author manuscript; available in PMC: 2024 Feb 7.
Published in final edited form as: Pancreas. 2021 Nov-Dec;50(10):1382–1391. doi: 10.1097/MPA.0000000000001936

TABLE 3.

Treatment Received by Study Participants

N = 2361, n (%)
Resection
  No surgery for primary site 1358 (57.5)
  Local tumor destruction 56 (2.4)
  Partial resection 681 (28.8)
  Total resection 231 (9.8)
  Total or partial unknown 35 (1.5)
Regional nodes examined
  0 1415 (59.9)
  1–90 842 (35.7)
  Not available 104 (4.4)
Regional nodes positive
  0–3 510 (21.6)
  4–86 348 (14.7)
  Not available 1503 (63.7)
Surgical margins
  Yes 276 (11.7)
  No 675 (28.6)
  Not available 1410 (59.7)
Radiation therapy at any CoC facility
  No 2084 (88.3)
  Yes 256 (10.8)
  Not available 21 (0.9)
Chemotherapy at any CoC facility
  No 1518 (64.3)
  Chemotherapy administered, type and number of agents not documented 50 (2.1)
  Single-agent chemotherapy 272 (11.5)
  Multi-agent chemotherapy 431 (18.3)
  Not available 90 (3.8)

CoC indicates Commission on cancer coding